Overactive Bladder Treatment Market Worth $5+ Billion, Globally, by 2028 at 3+% CAGR | The Insight Partners

NEW YORK, Oct. 21, 2022 /PRNewswire/ -- The Insight Partners published latest research study on "Overactive Bladder Treatment Market Size, Share, Revenue, Growth Strategy, Industry Trends and Forecast to 2028 – COVID-19 Impact and Global Analysis – by Pharmacotherapy, Disease Type, and Geography," the global overactive bladder treatment market size was valued at USD 4,295.93 million in 2021 and is projected to reach USD 5,333.92 million by 2028; it is estimated to grow at a CAGR of 3.1% from 2022 to 2028.

Download Sample PDF Brochure of Overactive Bladder Treatment Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at: https://www.theinsightpartners.com/sample/TIPRE00004082/

Global Overactive Bladder Treatment Market Report Scope, Segmentations, Regional & Country Scope:

Browse key market insights spread across 209 pages with 110 list of tables & 80 list of figures from the report, "Overactive Bladder Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Pharmacotherapy (Anticholinergics, Mirabegron, Botox, Neurostimulation, and Intravesical Instillation) and Disease Type (Idiopathic Overactive Bladder and Neurogenic Bladder)" in detail along with the table of contents: https://www.theinsightpartners.com/reports/overactive-bladder-treatment-market

Global Overactive Bladder Treatment Market: Competitive Landscape and Key Developments

Key players operating in the overactive bladder treatment market include Alembic Pharmaceuticals Limited; Astellas Pharma Inc; Pfizer Inc.; AbbVie Inc; Teva Pharmaceutical Industries Ltd; Endo Pharmaceuticals Inc.; Hisamitsu Pharmaceutical Co., Inc; Medtronic Plc; Allergan; and Colorado Urology Associates, PLLC. These players are focusing on expanding, diversifying their market presence, and acquiring a novel customer base, thereby tapping into prevailing business opportunities.

In February 2022, Alembic Pharmaceuticals received approval from the US health regulator for its generic version of fesoterodine fumarate extended-release tablets, used for overactive bladder in adults with symptoms of urinary incontinence, urgency, and frequency. The US Food & Drug Administration (USFDA) approved strengths of 4 mg and 8 mg of fesoterodine fumarate extended-release tablets for the Abbreviated New Drug Application (ANDA).

In February 2022, AbbVie announced that the US Food and Drug Administration (FDA) had approved BOTOX for the treatment of detrusor (bladder muscle) overactivity associated with a neurologic condition in pediatric patients five years of age and older who have an inadequate response to or are intolerant of anticholinergic medication.

In April 2021, Medtronic plc announced approval from the US Food and Drug Administration (FDA) to proceed with an investigational device exemption (IDE) trial to evaluate its internally developed implantable tibial neuromodulation (TNM) device—a therapy designed to provide relief from symptoms of bladder incontinence. 

In July 2020, Hisamitsu Pharmaceutical Co., Inc. announced the approval of manufacturing and marketing for OABLOK PATCH in Thailand. The product is a systemic transdermal formulation developed using Hisamitsu's TDDS (Transdermal Drug Delivery System) technology for treating overactive bladder with symptoms such as urinary urgency and frequent urination.

Inquiry Before Purchase: https://www.theinsightpartners.com/inquiry/TIPRE00004082/

Increasing Prevalence of Overactive Bladder in Geriatric Population:

The report highlights the key factors driving the global overactive bladder treatment market and prominent players' developments. The growth of the global overactive bladder treatment market is primarily attributed to the increasing prevalence of urinary incontinence and the growing incidence of urinary tract infections. However, the recalls of therapeutic drugs hamper the market growth.

In 2021, North America held the largest share of the overactive bladder treatment market. The growing prevalence of overactive bladder in the geriatric population and the increasing incidence of neurological diseases are propelling the growth of the overactive bladder treatment market in North America. Also, the suitable reimbursement scenarios for the treatment of overactive bladder and the increase in research activities fuel the growth of the North America market. According to Cleveland Clinic Organization, ~33 million adults in the US are affected by an overactive bladder. Further, an article by John Wiley & Sons, Inc. stated that about 17% of the US population suffers from this condition.

According to Parkinson's Foundation, about 1 million people in the US are living with Parkinson's Disease, which is about to rise to 1.2 million by 2030. Neurological diseases like Parkinson's disease cause overactive bladder due to disruption in the bladder and brain. Hence, the rising prevalence of neurological disorders in North America is driving the overactive bladder market in this region. Although most public payers across Canada restrict or do not fund newer costly treatments, they fund the basic treatment necessary for the overactive bladder. For instance, the treatment for overactive bladder in Ontario is funded by Ontario Public Drug Programs (OPDP). Thus, the suitable reimbursement options available for treating the condition are propelling the market growth in the country.

Speak to Research Expert: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00004082

Increasing Number of Mergers and Acquisitions Creating Opportunities for Global Overactive Bladder Treatment Market:

Through mergers and acquisitions (M&A), companies can gain a competitive edge by entering new markets and acquiring new technologies. The mergers and acquisitions in the overactive bladder treatment market are creating growth opportunities for the companies. In November 2020, Coloplast, a Danish medical device company, acquired Nine Continents Medical, which has developed implantable tibial nerve stimulation (ITNS) treatment for overactive bladder. With this acquisition, Coloplast aims to expand its Interventional Urology business segment to be able to cater to the large patient population worldwide. In July 2021, Uro Medical strengthened its urology portfolio with the acquisition of Micron Medical, which offers wirelessly powered, injectable, microtechnology neurostimulators focused on treating overactive bladder. These neurostimulators, which can be easily incorporated into patients' daily lives, offer a convenient, safe, minimally invasive, and cost-effective urological treatment option.

In February 2021, Axonics Modulation Technologies, Inc., a medical technology company, acquired Contura Ltd. and its proprietary product, Bulkamid, which is a urethral bulking agent for women with stress urinary incontinence (SUI). Axonics produces and markets novel implantable sacral neuromodulation (SNM) devices for treating urinary and bowel dysfunction. The acquisition of Contura Ltd. provides it an opportunity to expand its SNM business worldwide and serve the large, highly underpenetrated SUI market. As per Axonics, ~20 million women suffer from SUI in the US alone. The company plans to offer urogynecologists and urologists a complete suite of clinically differentiated incontinence solutions to treat their patients.

Global Overactive Bladder Treatment Market: Segmental Overview

Based on pharmacotherapy, the global overactive bladder treatment market is segmented into mirabegron, botox, neurostimulation, anticholinergics, and intravesical instillation. The mirabegron segment held the largest market share in 2021. However, the neurostimulation segment is expected to register the highest CAGR during the forecast period.

Based on disease type, the global overactive bladder treatment market is bifurcated into idiopathic overactive bladder and neurogenic overactive bladder. The idiopathic overactive bladder segment held a larger market share in 2021. Moreover, the market for this segment is expected to grow at a higher CAGR during the forecast period.

Quickly Purchase Premium Copy of Overactive Bladder Treatment Market Growth Report (2022-2028) at: https://www.theinsightpartners.com/buy/TIPRE00004082/ 

The global overactive bladder treatment market witnessed growth due to increasing overactive bladder symptoms observed in COVID-19-recovered patients. COVID-19 virus not only affected the respiratory tract of the body, but it also affected the bladder of the patient. Further, the COVID-19 infection resulted in urine cytokine elevation that increased the frequency of urination, leading to overactive bladder disorder among COVID-19 patients. An overactive bladder, cystitis, and other bladder dysfunctions resulting in bladder inflammation are expected to occur after a COVID-19 infection. Thus, the increasing overactive bladder symptoms in COVID-19 patients propelled the global overactive bladder treatment market growth during the pandemic.

Go through further research published by The Insight Partners:

Spiral Membrane Market – The global spiral membrane market size is expected to grow from US$ 7.6 billion in 2022 to US$ 14.2 billion in 2028 with an estimated CAGR of 10.9% from 2022 to 2028.    

Thermal Interface Materials Market - The global thermal interface materials market size is expected to grow from US$ 2.9 billion in 2021 to US$ 6.5 billion by 2028 at a CAGR of 11.3% between 2022 and 2028.

High Purity Alumina Market - The global high purity alumina market size is expected to grow from US$ 2.1 billion in 2021 to US$ 5.5 billion by 2028 at a CAGR of 15.1% between 2022 and 2028.

Battery Separators Market - The global battery separators market size is expected to grow from US$ 5.6 billion in 2022 to US$ 9.5 billion by 2028; it is estimated to grow at a CAGR of 9.0% between 2022 and 2028.

Automotive Foam Market – The global automotive foam market size is expected to grow from US$ 56.6 billion in 2021 to US$ 109.5 billion by 2028 at a CAGR of 9.3% between 2022 and 2028.

Wind Energy Market - The global wind energy market size is expected to grow from US$ US$ 156.8 billion in 2021 and it is anticipated to grow at a CAGR of 5.0% from 2022 to 2028.

Maritime Information Market - The global maritime information market size was valued at US$ 1,882.01 million in 2021 and it is expected to grow at a CAGR of 6.2% from 2022 to 2028.

Print Management Software Market - The global print management software market size is projected to grow from US$ 2,000.99 million in 2022, it is estimated to grow at a CAGR of 15.2% from 2022 to 2028.

Diabetes Therapeutics Market - The global diabetes therapeutic market size is expected to grow from USD 58.46 billion in 2021 to USD 91.73 billion by 2028, with an estimated CAGR of 6.8% from 2022 to 2028.

LED Lighting Market - The global LED lighting market size is expected to grow from US$ 57.5 billion in 2021 and it is expected to grow at a CAGR of 10.7% from 2022 to 2028.

Molded Interconnect Devices Market - The global molded interconnect device (MID) market size is expected to grow from US$ 1,203.5 million in 2021 to US$ 2,711.9 million by 2028 at a CAGR of 14.5% from 2022 to 2028.

Digital Education Market - The global digital education market size is expected to grow from US$ 11.62 billion in 2021 to US$ 54.95 billion by 2028 at a CAGR of 26.1% between 2022 and 2028.

Biometric System Market - The global biometric system market size is expected to grow from US$ 43 billion in 2021 to US$ 85 billion by 2028 at a CAGR of 14.5% between 2022 and 2028.

Wifi-as-a-Service Market - The global wi-fi as a service market size is projected to grow from US$ 3.66 billion in 2021 to US$ 13.34 billion by 2028; it is expected to grow at a CAGR of 19.5% during 2022–2028.

Sound Recognition Market - The global sound recognition market size is projected to grow from US$ 3.84 billion in 2021 to US$ 9.70 billion by 2028; it is expected to grow at a CAGR of 14.5% from 2022 to 2028.

Network Transformation Market - The global network transformation market size is expected to grow from US$ 19.27 billion in 2021 to US$ 175.34 billion by 2028 at a CAGR of 40.6% between 2022 and 2028.

Molded Interconnect Devices (MID) Market - The global molded interconnect device (MID) market size is expected to grow from US$ 1,203.5 million in 2021 to US$ 2,711.9 million by 2028 at a CAGR of 14.5% from 2022 to 2028.

Data Collection and Labeling Market - The global data collection and labeling market size is expected to grow from US$ 1.82 billion in 2021 to US$ 9.07 billion by 2028 at a CAGR of 27.2% between 2022 and 2028.

Customer Data Platform Market - The global customer data platform market size is expected to grow from US$ 2,672.5 Mn in 2021 to US$ 14,847.1 Mn by 2028 at a CAGR of 28.2% between 2022 and 2028.

Vehicle Tracking Systems Market - The global vehicle tracking systems market size is expected to grow from US$ 13.67 billion in 2021 to US$ 23.70 billion by 2028; it is expected to grow at a CAGR of 8.7% from 2022 to 2028.

Autonomous Last Mile Delivery Market - The global autonomous last mile delivery market size is expected to grow from US$ 57.67 billion in 2021 to US$ 68.95 billion by 2028; it is expected to register a CAGR of 3.0% from 2022 to 2028.

ISDN Modem Market - The global ISDN modem market size was valued US$ 982.97 thousand in 2022, it is estimated to register a CAGR of -80.6% from 2022 to 2024.

Semiconductor Bonding Market - The global semiconductor bonding market size was valued US$ 669.48 million in 2022, it is estimated to grow at a CAGR of 8.2% from 2022 to 2028.

Recycled Ocean Plastics Market - The global recycled ocean plastics market size was valued at US$ 14,432.91 million in 2022, it is expected to grow at a CAGR of 8.5% from 2022 to 2028.

EDM Wire Market - The global EDM wire market size is expected to grow from US$ 1,497.50 million in 2022, it is estimated to grow at a CAGR of 7.6% from 2022 to 2028.

Seam Welding Machine Market - The global seam welding machine market size was valued US$ 1,142.87 million in 2022, it is estimated to grow at a CAGR of 4.0% from 2022 to 2028.

Electric Coolant Pump Market - The global electric coolant pump market size was valued US$ 467.46 million in 2022, it is estimated to grow at a CAGR of 16.8% from 2022 to 2028.

Smart Manufacturing Market - The global smart manufacturing market size was valued US$ 258.72 billion in 2022, it is estimated to grow at a CAGR of 6.0% from 2022 to 2028.

Respiratory Care Devices Market - The global respiratory care devices market size is expected to grow from US$ 18,114.31 million in 2021 to US$ 32,761.82 million by 2028; it is estimated to register a CAGR of 8.9% from 2021 to 2028.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/overactive-bladder-treatment-market

Logo: https://mma.prnewswire.com/media/1586348/The_Insight_Partners_Logo.jpg

SOURCE The Insight Partners